Pharmacy Times

Scott Soefje highlights how oncology pharmacists can advance patient-centered care and drive innovation in clinical research.

Candy Peskey highlights the necessary role of oncology pharmacists in patient care and enrollment in clinical trials.

Access to certain drugs may be limited through tighter formulary controls and utilization management by Medicare Part D plans dealing with higher costs

Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.

Semaglutide (Wegovy) From: Novo Nordisk The FDA has approved a new indication for the use of semaglutide, to reduce the risk of

Machine Learning Can Predict Early Alzheimer Disease A Machine learning model demonstrated the potential to improve early detection and

As summer approaches, remind patients to go back to basics with sunscreen and self-examinations.

Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.

Jodi Taraba offers valuable insights on the benefits of involving oncology pharmacists in clinical trial research to advance treatment and care for patients with cancer.

Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs. Specialty medications require significant investments and specialized handling due to their complex nature, short shelf lives, and focused patient populations. However, building the necessary infrastructure and distribution networks poses high costs and operational barriers for manufacturers.